by Brian Shilhavy
Editor, Health Impact News
“Since the emergency use authorization of the COVID-19 vaccines in December of 2020, through the latest update of the VAERS database on October 14, 2022, 84% of all deaths reported after vaccination for the past 31+ years have been reported following COVID-19 vaccines. ”
by Marco Cáceres
The U.S. Food and Drug Administration (FDA) has refused a Freedom of Information Act (FOIA) request to release the autopsy results of people whose deaths were reported to the Vaccine Adverse Event Reporting System (VAERS) after receiving a COVID-19 shot.
by Brian Shilhavy
“Another 142 new cases of COVID-19 vaccine injuries to babies and toddlers between the ages of 6 months and 4 years old were added to the U.S. Government run VAERS (Vaccine Adverse Events Reported System) database today, bringing the total number of cases filed for this age group to 829 since the shots were authorized by the FDA a few weeks ago in June. (Source.)
Brain and heart injuries, hallucinations, anaphylactic shock, seizures, skin rashes, gastrointestinal injuries, hemorrhaging, and other serious conditions continue to be listed as side effects to these toxic shots being injected into babies and toddlers.”
By
“A prospective study in Thailand conducted during the country’s national COVID-19 vaccination campaign for adolescents showed what one physician described as a “stunning” association between myocarditis and the Pfizer-BioNTech vaccine.
The preprint, accepted for publication in a peer-reviewed journal, involved 314 participants ages 13-18 who were healthy and without abnormal symptoms after receiving their first vaccine dose.”
by Michelle Goldstein
I was raised like most Americans. Doctors were highly respected in my parents’ home and their authority on health matters was not questioned. My parents followed their physicians’ advice on healthcare and I was no different when raising my own children.
I was careful to follow the health and dietary recommendations when my children were young and I believed that vaccines would keep my children safe from disease. In fact, I believed wholeheartedly that the more vaccines we had, the better protected my family would be. Out of love, I gave myself and my children every new vaccine available. I consulted with our physicians and with full trust followed their advice.
After consulting with my trusted obstetrician, who had delivered all three of my children, along with my pediatrician, I made the fateful decision to vaccinate my two daughters with the HPV vaccination series. Several months later, one child developed a serious case of the debilitating autoimmune disorder, Crohn’s disease, which robbed her of several years of her childhood. We continue to battle this ravaging disease.
It took many years and countless consultations with integrative, holistic physicians before I recognized the link between the HPV vaccination and my daughter’s illness. To be honest, there was only one holistic physician, who specialized in autism, who helped us make this connection. The many others, including a certified functional medicine doctor, failed to connect these two events.
I now believe wholeheartedly that the HPV vaccine and my daughter’s development of a life-threatening autoimmune disorder was no coincidence…
Authors: Freda Birrell, Chair, UK Association; Steve Hinks, Press Officer, UK Association
Our UK Association of HPV Vaccine Injured Daughters (AHVID) was established at the beginning of 2015. Families and their daughters from the north of Scotland to the south of England, Wales and Northern Ireland have joined together to give support to each other and raise awareness of the dangers of the HPV vaccines, Cervarix and Gardasil. The primary focus of this organisation is to assure our members that they are no longer on their own and by working together we can achieve so much more. In our opinion, these vaccines have caused many serious health issues which need immediate investigation.
Our facebook group ‘Parents of daughters suffering long term side effects following HPV vaccination’ is an established group for families whose young people have suffered adverse events following vaccination. Members are from countries worldwide who give each other valuable support and comfort in times of crisis. They understand what the families are going through and they share their experiences, good and bad, giving comfort and advice to one another when required. They have become an international family doing their best to cope when the world outside ignores them. Their aim is to be there for one another.
Please see the photos of some of our family members – this only represents a small section of our association – but these are real people, real families who all share one thing in common – their daughters became ill following HPV vaccination and these illnesses have lasted for many years.
Our aims are:
Freda Birrell (Scotland) is in the Chair; Caron Ryalls (Yorkshire) is Secretary; Steve Hinks (Cumbria) is Press officer and Julie Jones (Midlands) is Political Activist.
For further information please contact Freda at jeanfreda8@btinternet.com or Caron at caronryalls2025@gmail.com or Steve Hinks atsteve@hinksfamily.co.uk (Press Officer)
This article in it’s entirety, is compliments of www.SaneVax.org
By Norma Erickson
The SaneVax team believes the narrow scope of the current investigation regarding the safety profile of HPV vaccines being conducted by the European Medicines Agency (EMA), will leave parents and medical professionals without answers to questions which may help them solve the mystery surrounding new medical conditions being reported not only in Denmark, but around the globe, after the administration of HPV vaccines.
Has the EMA put POTS and CRPS under an investigative microscope in order to blur the overall picture regarding the safety profile of HPV vaccines? Have those in charge never heard the expression, “you can’t see the forest for the trees?”
Norwegian journalist, Per Egil Hegge, puts the entire issue into focus when he stated:
A scientific environment, no matter the subject, where it is not allowed to ask questions, has thrown its future on the scrap heap and nailed its own death sentence on the wall.
Apparently, open discussions on the topic of HPV vaccines are tabu. This is simply not acceptable. If open honest scientific investigations are not forthcoming, young people around the world will continue to have their futures thrown on the proverbial scrap heap.
If serious investigations are not conducted, it may well be the public’s trust in national health authorities that is thrown on the trash heap.
Until such time as HPV vaccines are proven to be safe, affordable, necessary and effective – everyone needs to remember that national health authorities are not infallible. Questions must be asked – answers must be forthcoming!
In view of the fact a request from Denmark was the impetus responsible for instigating the EMA investigation, the Danish Health and Medicines Authority was the logical place to try and obtain some of the answers so desperately needed by medical professionals trying to diagnose and cure the survivors of potential reactions to HPV vaccines; answers which are also needed by the hundreds of Danish parents of affected girls.
The following recounts a 2-day interchange initiated by us via email to Mr. Henrik G. Jensen, Unit Leader of the Family and Consumer Affairs Division, Danish Health and Medicines Authority (Sundhedsstyrelsen). Communications began at the request of multiple Danish parents concerned about their daughter’s future health due to the host of mysterious medical conditions experienced soon after the administration of HPV vaccines.
Mr. Jensen is to be commended for his rapid response to all communications from the SaneVax team. However, Mr. Jensen was not quite as efficient at answering the questions which were asked of him. This is unfortunate.
Mr. Jensen was not forthcoming with adequate answers to the questions posed by the SaneVax team and has declared, ”I think we should conclude our discussion here.”
Therefore, in the interest of public health and safety the SaneVax team is left with no alternative but to move the conversation to a public venue.
Dear Mr. Jensen,
SaneVax Inc. is an international non-profit organization dedicated to the promotion of only Safe, Affordable, Necessary and Effective (SANE) vaccines and vaccination practices. As president of SaneVax, I am writing to you on behalf of the many Danish families who have daughters with mysterious new medical conditions after the administration of HPV vaccines.
One of these parents recently sent the SaneVax team a transcript of your interview for TV2’s Good Morning Denmark show which was broadcast on July 14th. During this interview, you were questioned about the current review of HPV vaccines being conducted by the EMA’s Pharmacovigilance committee (PRAC).
Some of the statements you made during this interview were mildly disturbing. For instance, you stated 2 women die of cervical cancer every week in Denmark, when the actual rate is only 1.5 according to the latest available World Health Organization statistics. But, we understand sometimes public health officials do things like rounding incident rates to the next higher number to make an impact on the public perception so as to help increase vaccination compliance.
The primary reason for this letter is your statement that Denmark is the only country having problems with high rates of serious adverse events after HPV vaccines. The interviewer responded to this by stating:
And let’s focus a bit on this, that it’s here in Denmark, that we experience that some of these girls who get the HPV vaccine get suspected symptoms afterwards. Because this is not the picture in, for example our neighboring country, Sweden, or basically in the rest of the world. They do not experience the girls come in and say that they are in pain, or I feel that my heart behaves ’weird’ after being given this vaccine. Why is it only here in Denmark?
You answered:
Yes. But that we, of course, have asked ourselves too, and we are also asked by our European colleagues – what is it that you experience? What is it that you are doing in Denmark? But Denmark is a tiny very well regulated, orderly country. We are good at reporting side effects. We care about it. And I think if there is a country you have to find something like this, it’s Denmark.
When we talk rare side effects, it may well be a side effect which is not found in any of the clinical trials as the basis for approval, and then it will typically be such a small Scandinavian country one finds it, as Denmark.
With all due respect, Mr. Jensen, this is simply not accurate. Please consider the following:
This is but a small sample. According to the World Health Organization (WHO), as of January 2014 fifty-two countries have included HPV vaccines in their national immunization programs. The SaneVax Team has been contacted by representatives from well over half of them seeking to understand the vast array of new medical conditions occurring in the wake of these programs.
Can you please explain how a person in your position as a department head within an organization whose mission is ’health for all – through safe and effective prevention and treatment’ is not aware of any of these events?
Also, according to Dr. Jesper Mehlsen’s best estimate as of June 11th, one in 500 girls who were vaccinated with Gardasil in Denmark experienced serious side effects. This translates into 200/100,000. I am sure you are well aware of the fact that the cervical cancer diagnosis rate in your country is only 12.1/100,000.
Can you please explain why your advice to those you are charged with protecting is to continue to use HPV vaccines despite the fact that the reported rate of serious adverse events in your own country far exceeds the risk of obtaining a cervical cancer diagnosis?
Medical consumers anxiously await your reply.
Signed on behalf of Danish families,
Norma Erickson, President
SaneVax Inc.
References:
Subject: SV: SaneVax Inc. on behalf of Danish Medical Consumers
Dear Norma Erickson,
Please be aware that in 2013 (latest official update) 114 women died of cervical cancer in Denmark.
Denmark is in accordance with advice given from EMA, FDA and WHO.
Best
Henrik G. Jensen
Danish Health and Medicines Authority
Subject: Re: SV: SaneVax Inc. on behalf of Danish Medical Consumers
Dear Henrik Jensen,
Thank you for your prompt response. I understand Denmark introduced HPV vaccines in 2008.
Do you have any theory as to why the cervical cancer mortality increased from 97 in 2012 to 114 in 2013?
Thank you for any insights you can offer.
Regards,
Norma Erickson
Subject: SV: SV: SaneVax Inc. on behalf of Danish Medical Consumers
Dear Norma Erickson,
Tahnk you for your mail.
Do you recognize that the number in your mail ”1.5” is wrong?
Do you recognize that the discussion on the tv program was about POTS and CRPS and not a general discussion on ADR?
Please be clear!
Best
Henrik G. Jensen
Subject: Re: SV: SV: SaneVax Inc. on behalf of Danish Medical Consumers
Dear Henrik Jensen,
Thank you for bringing the error in the original letter to my attention. I went back and checked the figures and found that I had inadvertently transposed a number when calculating the number per week. I sincerely appreciate your assistance.
I did indeed recognize that the television program was limited to a discussion of POTS and CRPS. Once again, these are conditions being diagnosed after HPV vaccine administration in many countries – NOT just Denmark!
That being said, on behalf of all the families in Denmark whose lives have been transformed after HPV vaccine use, I renew my request for answers to the following questions:
Thank you in advance for providing this much needed information to the people of your country. Please show them you are not allowing POTS and CRPS to be put under the investigative microscope in order to blur the overall picture regarding the safety profile of HPV vaccines. Let them know you are looking out for their health and well-being.
Signed on Behalf of the Citizens of Denmark,
Norma Erickson, President
SaneVax Inc.
SV: SV: SV: SaneVax Inc. on behalf of Danish Medical Consumers
Dear Norma Erickson,
Thank you for your mail.
Your information ”I sincerely appreciate your assistance” is simply not good enough. You owe me an apology – I think you should be serious about this and think once again about the words you use.
About the number of POTS associated with Gardasil – please be aware of the official numbers in Europa. The last official information from EMA dated December 2014 was 66 cases of POTS with the largest number in Europe from Denmark – one of the smallest countries in the world. Please check the official numbers. The EMA conclude that a link between Gardasil and POTS can neither be confirmed nor be ruled out. Once again you owe me an apology.
As far as your first question EMA concludes that the overall benefit/risk balance of Gardasil remains positive. And please be aware that this opinion is shared by FDA, WHO and all European countries. And you also knows this!
Denmark included Gardasil in the childhood vaccination program January 1, 2009. As far as the mortality rate is concerned you have to look at a wider span of years to have the full picture. We will expect to see a significant decrease in the numbers in the years to come – and combining the screening and vaccination programs we will be able to almost eradicate cervical cancer. More than 20.000 European women die from cervical cancer every year.
New Danish research by the Danish Cancer Society has already shown that the Danish vaccination program for HPV works. Among the HPV vaccinated women born in 1993 and 1994, the risk of having precursors to cervical cancer is reduced by 73% compared with unvaccinated. Scientific studies from among others US, Australia and Sweden has shown the same.
I think we should conclude our discussion here.
Best
Henrik G. Jensen
First, it must be noted that there was an error in the initial email SaneVax sent to Mr. Jensen, a fact which he pointed out only after being asked if he had any theory as to why the cervical cancer mortality incidence in Denmark increased from 97 in 2012 to 114 in 2013 – an increase which occured after the introduction of HPV vaccines.
The information on 2013 cervical cancer mortality rates was not available to the SaneVax team at the time the email was written. Nevertheless, the 1.5 cervical cancer deaths per week in Denmark should have read 1.8 cervical cancer deaths per week according to the 2012 statistics compiled by the World Health Organization which were referenced in the email. Despite the math error (which was the author’s fault) the correct figure available to the author was still lower than the 2 cancer deaths per week Mr. Jensen quoted on the Good Morning Denmark Show.
The truth be told, whether the most accurate figure is 1.5, 1.8 or 2.0/100,00 is immaterial – all three numbers pale in comparison to the number of serious medical conditions occurring in Denmark (and other countries) after Gardasil administration.
Both Mr. Jensen and the SaneVax team were working with the data available to them at the time the emails were composed, hence some of the confusion. The truth of the matter is neither SaneVax nor Mr. Jensen have a clear picture of the benefit/risk profile of HPV vaccination programs. That is precisely why open scientific discussions are needed.
It is worth noting that SaneVax provided references to all data sources used in their communications, unless the information referenced had been provided by Mr. Jensen. Mr. Jensen did not grant SaneVax the same courtesy. The clear implication was the SaneVax team should simply trust his word. A prime example of this is Mr. Jensen’s request that SaneVax check the official numbers for POTS cases reported after HPV vaccinations in Europe without providing the source of said data.
Mr. Jensen stated,
The EMA conclude that a link between Gardasil and POTS can neither be confirmed nor be ruled out.
This statement is true. However, at no time has any SaneVax team member stated a link had been established between HPV vaccine administration and any subsequently experienced medical condition. Throughout the history of our organization, we have simply called for scientific investigations to determine whether or not such a link exists.
One could justifiably state a link between HPV vaccines and any adverse health condition will never be established unless one is looked for. Another reason open discussions with scientific professionals from both sides of the debate followed by serious investigations are such a critical need.
Mr. Jensen’s statements regarding the EMA/FDA/WHO positions on HPV vaccines was irrelevant to the subject being discussed. He was correct in stating that the SaneVax team was well aware of their position. However, all questions from SaneVax to Mr. Jensen were exclusively referring to Sundhedsstyrelsen’s position.
Mr. Jensen stated:
New Danish research by the Danish Cancer Society has already shown that the Danish vaccination program for HPV works. Among the HPV vaccinated women born in 1993 and 1994, the risk of having precursors to cervical cancer is reduced by 73% compared with unvaccinated. Scientific studies from among others US, Australia and Sweden has shown the same.
Mr. Jensen and all of the health authorities quoted should be well aware of the fact that reducing the prevalence of an infection which clears on its own 90% of the time (within two years) does not necessarily translate into a reduction of cervical cancer cases in the future. The same health authorities should be well aware of the fact that reducing so-called pre-cancerous lesions, which also frequently resolve on their own without medical intervention does not necessarily predict a reduction in cervical cancer rates.
Theoretically, these health authorities are aware of the following quote from Chapter 2 of the IARC’s COLPOSCOPY AND TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA: A BEGINNER’S MANUAL, published by the World Health Organization, which states:
Despite women’s frequent exposure to HPV, development of cervical neoplasia is uncommon. Most cervical abnormalities caused by HPV infection are unlikely to progress to high-grade CIN or cervical cancer, as most of them regress by themselves. The long time frame between initial infection and overt disease indicates that several cofactors (e.g., genetic differences, hormonal effects, micronutrient deficiencies, smoking, or chronic inflammation) may be necessary for disease progression. Spontaneous regression of CIN may also indicate that many women may not be exposed to these cofactors.
The only true measure of HPV vaccine efficacy will be a reduction in diagnosed cervical cancer cases in those vaccinated along with a similar reduction failing to occur in those who are unvaccinated. All national and international health authorities referred to by Mr. Jensen should be well aware of this fact. If they are not, they are deluding themselves and the public.
Until such time as a real reduction in cervical cancer cases is demonstrated, medical professionals and medical consumers are left with multiple questions for which they deserve answers – if they are to have any hope of preserving the health and well-being of the next generation.
Among these questions are those Mr. Jensen left unanswered:
These 3 questions are but the tip of the iceberg.
If Denmark’s health authorities were seriously interested in determining the true risk/benefit profile of HPV vaccines, they would have considered posing some questions being put forth by medical professionals, scientific research teams and medical consumers in Denmark and around the world.
Some of these questions are:
Again, the above questions are simply a sample of the questions the Danish Health and Medicines Authority should have put forth to the European Medicines Agency (EMA) if they were serious about investigating the benefit/risk profile of HPV vaccines.
One has to wonder why Sundhedsstyrelsen seems content to put two quite specific conditions under the microscope while ignoring the rest of the picture.
Could it have anything to do with the fact that around half of the Danish Health and Medicines Authority’s (Sundhedsstyrelsen) funding comes directly, from global pharmaceutical giants? Only time will tell.
In the meantime, medical consumers and those who administer HPV vaccines are on their own. They need to start asking pertinent questions such as those listed above and demanding answers.
Until such time as HPV vaccines are proven to be safe, affordable, necessary and effective, everyone needs to remember that national health authorities are not infallible.
Every prescription medication ever removed from the market was first deemed safe and effective by national health authorities such as the FDA and Sundhedsstyrelsen, not to mention international authorities like the EMA. (A list of 35 such drugs approved by the FDA and later pulled from the market is here.)
Gardasil, Cervarix and Gardasil 9 are rapidly becoming ’poster children’ for vaccines by demonstrating everything that can possibly go wrong with a vaccine. The laundry list of unanswered questions about these vaccines seems to expand on a daily basis.
Medical consumers have a right to receive satisfactory answers to any questions they have regarding medical interventions prior to granting their consent. This is particularly true of vaccines – injected material is not easily removed.
Anyone who administers HPV vaccines has a duty to ask relevant questions until they are satisfied with the answers. No medical intervention is right for everyone. Clearly, HPV vaccine risks outweigh the benefits for some people. Medical professionals must be completely and accurately informed in order to make sure HPV vaccines are the right choice for the person sitting in front of them.
Medical professionals and medical consumers: Remember the consequences resulting from use of Thalidomide, Darvon, Darvoset, DES, antipsychotic drugs, and Vioxx – just to name a few. All of them were approved as safe and effective before leaving massive devastation in their wake.
Do your research – it is easy to halt medications when there is a problem – you cannot unvaccinated!
This article in it’s entirety, is compliments of www.SaneVaX.org
by sattkisson